Several ABA receptors have been reported[@R8]-[@R13], although many of them remain unconfirmed[@R15]-[@R16]. Recently, a family of novel START domain proteins, known as PYR/PYLs (pyrabactin resistance1/PYR1-likes, also known as RCARs), were identified as ABA receptors. Several of the PYR/PYLs were shown to interact with and inhibit clade-A PP2Cs (type 2C protein phosphatases)[@R11]-[@R13]. The PP2Cs (ABI1, ABI2, HAB1, PP2CA/AHG3) negatively regulate ABA responses[@R13]. On the contrary, a subfamily of ABA-activated SnRK2s are positive regulators of ABA signaling[@R17]-[@R21]. Through unknown mechanisms, the inhibition of the negatively acting PP2Cs leads to the successful activation of a subfamily of SnRK2 kinases (SnRK2.2, SnRK2.3 and SnRK2.6 in *Arabidopsis*), which phosphorylate the basic leucine zipper (bZIP) transcription factors called ABFs/AREBs[@R22]-[@R23]. The ABFs bind to ABA-responsive promoter elements (ABRE) to induce the expression of ABA-responsive genes[@R1].

The present study was aimed at defining the core components of the ABA response pathway that are both necessary and sufficient for ABA perception, signaling and finally ABA-responsive gene expression. ABA-dependent phosphorylation of ABF2 at amino acid residues S26, S86, S94 and T135 was suggested to be important for stress responsive gene expression in *Arabidopsis*[@R23]. We used transient activation analysis with protoplasts from the *snrk2.2/2.3/2.6* triple mutant to determine the role of ABF2 phosphorylation and its dependence on SnRK2s for ABA-responsive gene expression. We have shown previously that the *snrk2.2/2.3/2.6* triple mutant is deficient in ABA responses[@R21]. As expected, transfection of *snrk2.2/2.3/2.6* protoplasts with ABF2 did not induce *RD29B-LUC* expression even in the presence of ABA, but co-transfection of ABF2 with SnRK2.6 resulted in induction of *RD29B-LUC* in an ABA-dependent manner ([Fig. 1a](#F1){ref-type="fig"}). Furthermore, ABF2 with alanine substitutions at all of the four phosphorylation sites was inactive, whereas aspartic acid substitutions at these sites led to a constitutively active ABF2 resulting in induction of *RD29B-LUC* expression even without ABA treatment ([Fig. 1a](#F1){ref-type="fig"}). Co-transfection of Ala-substituted ABF2 with SnRK2.6 led to only a very low level of *RD29B-LUC* induction ([Fig. 1a](#F1){ref-type="fig"}). Substitution of lysine 50, a conserved residue critical for ATP-binding and kinase activity, with asparagine (K50N) inactivates SnRK2.6 in phosphorylation assays *in vitro* (our unpublished data). Co-transfection of ABF2 with SnRK2.6^K50N^ did not induce *RD29B-LUC* expression ([Fig. 1a](#F1){ref-type="fig"}), demonstrating that the kinase activity is necessary for ABF2 activation. Transfection of ABF2 alone in wild type protoplasts induced a low level of *RD29B-LUC* expression under ABA treatment, which is consistent with the presence of a low basal level of endogenous ABA signaling components in the protoplasts ([Supplementary Fig. 1a](#SD1){ref-type="supplementary-material"}). These results show that SnRK2.6 mediates ABF2 activation in an ABA-dependent manner, and that ABF2 phosphorylation is sufficient for ABA-induction of *RD29B-LUC* expression.

We next tested the effect of ABI1 and PYR1 on ABA-induction of *RD29B-LUC* expression. Transfection of ABI1 together with ABF2 and SnRK2.6 resulted in inhibition of *RD29B-LUC* expression ([Fig. 1b](#F1){ref-type="fig"}, [Supplementary Fig. 1a](#SD1){ref-type="supplementary-material"}). This shows that ABI1 negatively regulates SnRK2.6- and ABF2-dependent activation of *RD29B-LUC* expression. Addition of PYR1 together with ABI1, SnRK2.6 and ABF2 enabled ABA-dependent induction of *RD29B-LUC* expression ([Fig. 1b](#F1){ref-type="fig"}, [Supplementary Fig. 1a](#SD1){ref-type="supplementary-material"}). However, addition of PYR1^P88S^ that is defective in interaction with and inhibition of PP2Cs[@R12] did not enable ABA-dependent induction of *RD29B-LUC* expression. The dominant *abi1-1* mutation (G180D) disrupts the interaction between ABI1 and PYR1[@R12]. Like the wild type ABI1, ABI^G180D^ also inhibited the effect of SnRK2.6 and ABF2 on *RD29B-LUC* expression in response to ABA, but this antagonistic effect could not be overcome by expression of PYR1 ([Fig. 1b](#F1){ref-type="fig"}, [Supplementary Fig. 1a](#SD1){ref-type="supplementary-material"}). This suggests that the ABI^G180D^ mutant protein retains the inhibitory activity but can no longer be regulated. Thus reconstitution with PYR1, ABI1, SnRK2.6 and ABF2 is sufficient to enable ABA-mediated gene expression in protoplasts, providing *in vivo* evidence to our previously proposed model of ABA signaling[@R12].

The PYR/PYL family consists of 14 members. Although genetic studies suggested redundancy in their function[@R12], it is not known whether all members can act as ABA receptors and transduce the ABA signal to induce gene expression. To address this question, we reconstituted the ABA signaling pathway with different members of the PYR/PYL family. Our results show that all of the tested PYR1/PYLs could antagonize the ability of ABI1 to inhibit ABA-dependent induction of *RD29B-LUC* expression in *snrk2.2/2.3/2.6* protoplasts, although not all PYR/PYL members were equally effective ([Fig. 1c](#F1){ref-type="fig"}). The results suggest that all of the PYR/PYLs are likely to function as ABA receptors. We also tested reconstitution of the ABA signaling pathway with different combinations of SnRK2 kinases, PP2Cs and receptors, and found that the SnRK2 kinases are inhibited by both the ABI1 and HAB1 PP2Cs, and PYR1 or PYL2 can antagonize this inhibition. The inhibitory effect of ABI1 was stronger than that of HAB1 in the reconstituted ABA signaling system in protoplasts ([Fig. 1b-d](#F1){ref-type="fig"}, [Supplementary Fig. 1](#SD1){ref-type="supplementary-material"}). The three clade A PP2Cs (ABI1, ABI2 and HAB1) were each capable of interacting with the three SnRK2 kinases (SnRK2.2, SnRK2.3 and SnRK2.6) in yeast two-hybrid (Y2H) assays, although with different intensities. For example, the ABI1 interaction was stronger than those of ABI2 and HAB1 ([Supplementary Fig. 2a](#SD1){ref-type="supplementary-material"}), which correlate with the level of inhibitory effect of ABI1 and HAB1 in the protoplast assay ([Fig. 1d](#F1){ref-type="fig"}, [Supplementary Fig. 1b](#SD1){ref-type="supplementary-material"}). A C-terminally truncated SnRK2.6 lacking amino acids 280-362 did not interact with ABI1 ([Supplementary Fig. 2a](#SD1){ref-type="supplementary-material"}), which is consistent with previous studies demonstrating that deletion of a short C-terminal domain abrogates the interaction between ABI1 and SnRK2.6 in yeast[@R19]. Bimolecular fluorescence complementation (BiFC) assays in tobacco show that ABI1 interacts with the SnRK2s in the nucleus as well as the cytosol, and that the C-terminal region of SnRK2.6 is required for the interaction with ABI1 ([Supplementary Fig. 2b](#SD1){ref-type="supplementary-material"}). Expression of the fusion proteins was verified by immunoblot analysis ([Supplementary Fig. 2c](#SD1){ref-type="supplementary-material"}). The interaction between ABI1 and SnRK2.6 *in vivo* was further confirmed by a co-immunoprecipitation assay using the tobacco protein extracts ([Supplementary Fig. 2c](#SD1){ref-type="supplementary-material"}).

PYR/PYLs inactivate clade A PP2Cs in an ABA-dependent manner[@R11]-[@R13]. In protoplast transactivation assays, we showed that PYR/PYLs can reverse the inhibitory effect of PP2Cs ([Fig. 1](#F1){ref-type="fig"}, [Supplementary Fig. 1](#SD1){ref-type="supplementary-material"}). We hypothesized that the PYR/PYLs may prevent the inhibitory effect of the PP2Cs by disrupting the interaction between the PP2Cs and the SnRK2s. We tested whether co-expression of PYLs might disrupt the interaction between PP2Cs and SnRK2s by yeast triple-hybrid assays. First, we reproduced the interaction of the ABI1, ABI2 and HAB1 PP2Cs (fused to the Gal4 activation domain (GAD)) with SnRK2.6 (fused to the Gal4 DNA binding domain (GBD)) by using the pBridge triple-hybrid vector ([Supplementary Fig. 3](#SD1){ref-type="supplementary-material"}). Next, we cloned into the SnRK2.6-pBridge construct the PYL5 and PYL8, which have been shown to act as potent inhibitors of the PP2Cs[@R13]. Nuclear localization of PYL5 and PYL8 in yeast is driven by fusion with a nuclear localization sequence present in the pBridge vector. Co-expression of PYL8 together with GBD-SnRK2.6 abrogated or reduced (depending on the dilution of the yeast culture) the interaction with GAD-ABI1 ([Supplementary Fig. 3](#SD1){ref-type="supplementary-material"}). Similar results were obtained when GBD-SnRK2.6 and GAD-ABI2 or GAD-HAB1 was tested with either PYL8 or PYL5, respectively ([Supplementary Fig. 3](#SD1){ref-type="supplementary-material"}). These results show that co-expression of a PYL impairs the interaction of ABI1, ABI2 and HAB1 PP2Cs with SnRK2.6.

We have reconstituted the apparent entire ABA signaling pathway for stress responsive gene expression by co-expression of the PYR/PYLs, PP2Cs, SnRK2s and ABF2 in *Arabidopsis* protoplasts ([Fig. 1b-d](#F1){ref-type="fig"}, [Supplementary Fig. 1](#SD1){ref-type="supplementary-material"}). To verify whether these are the minimal signaling components that are both necessary and sufficient for ABA signaling in the absence of other cellular components, we attempted to reconstitute the pathway *in vitro*. We constructed recombinant MBP-SnRK2.6, and found that it is capable of phosphorylating an ABF2 fragment as well as autophosphorylation ([Fig. 2a and b](#F2){ref-type="fig"}). Incubation of GST-ABI1 but not GST with SnRK2.6 before the kinase assay substantially decreases ABF2 phosphorylation by the recombinant SnRK2.6 ([Fig. 2a](#F2){ref-type="fig"}). SnRK2.6 pulled down from extracts of ABA-treated plants is also active in phosphorylating ABF2 but SnRK2.6 from untreated plants is not. This phosphorylation is also inhibited by GST-ABI1 ([Fig. 2c](#F2){ref-type="fig"}). ABI1 added after ABF2 phosphorylation by SnRK2.6 is not as effective in reducing the level of phosphorylation ([Fig. 2a](#F2){ref-type="fig"}), suggesting that ABI1 inhibits ABF2 phosphorylation by dephosphorylating SnRK2.6 ([Fig. 2a](#F2){ref-type="fig"}). Indeed, we found that both ABI1 and ABI2 efficiently dephosphorylated SnRK2.6 ([Fig. 2d](#F2){ref-type="fig"}). The autophosphorylated Ser175 is essential for the kinase activity of SnRK2.6 *in vitro*[@R24]. We tested and found that ABI1 can dephosphorylate a synthetic phosphopeptide corresponding to amino acids His170-Pro180 of SnRK2.6, which is phosphorylated at Ser175 (HSQPKpSTVGTP; [Fig. 2e](#F2){ref-type="fig"}). These results suggest that ABI1 may deactivate SnRK2.6 by dephosphorylating Ser175.

When His-PYR1 is incubated together with GST-ABI1 and MBP-SnRK2.6, SnRK2.6-mediated phosphorylation of ABF2 is significantly recovered in the presence of 2 μM (+)-ABA ([Fig. 3a and b](#F3){ref-type="fig"}). Without ABA, His-PYR1 cannot reverse the inhibitory effect of ABI1 on SnRK2.6-mediated phosphorylation of ABF2 ([Fig. 3a](#F3){ref-type="fig"}). PYR1^P88S^, which cannot bind to and inhibit ABI1[@R12], is not capable of reversing the inhibitory effect of ABI1 even in the presence of ABA ([Fig. 3a](#F3){ref-type="fig"}). We found that in the presence of ABA, PYL8 or PYL5 can prevent the dephosphorylation of SnRK2.6 by ABI1 or ABI2 ([Fig. 2d](#F2){ref-type="fig"}). These data are consistent with results from the protoplast transactivation assays, and show that it is possible to reconstitute ABA activation of ABF2 phosphorylation *in vitro*. Importantly, ABF2 phosphorylation status in this reconstituted *in vitro* system responds to ABA in a concentration-dependent manner ([Fig. 3c](#F3){ref-type="fig"}). The apparent EC50 of this response is 0.8 μM, which is similar to the IC50 value for ABA inhibition of seed germination[@R11] and falls within the physiological range of ABA concentrations in plants. Similar ABA responses were observed when ABA-activated SnRK2.6 isolated from plants instead of recombinant SnRK2.6 was used in the reconstitution assay ([Supplementary Fig. 4a](#SD1){ref-type="supplementary-material"}). Furthermore, reconstitution was also achieved when the PP2C protein HAB1 was used instead of ABI1 ([Supplementary Fig. 4b](#SD1){ref-type="supplementary-material"}). Our protoplast and *in vitro* reconstitution results support a model in which PYR1 (and PYLs) binds ABA, and then interacts with and is able to inactivate the PP2Cs. The ABA-bound receptors also disrupt the interaction between the PP2Cs and the SnRK2 kinases. These actions of the receptors prevent the dephosphorylation and thereby relieve inhibition of the SnRK2s by the PP2Cs. The relieved SnRK2s can then phosphorylate ABFs to activate ABA-responsive genes.

Consistent with our model, we showed previously that the SnRK2s are substantially less activated by ABA in the *pyr1pyl1pyl2pyl4* mutant compared with the wild type[@R12]. The model also predicts that the SnRK2s may be constitutively activated in mutant plants that are deficient in the PP2Cs. Indeed, the PP2C triple mutant *abi1-2hab1-1pp2ca-1* shows a constitutive activation of 42 and 45 kD kinases, which correspond to SnRK2.2/2.3 and SnRK2.6, respectively ([Fig. 4a](#F4){ref-type="fig"}). This mutant displays a constitutive ABA response phenotype in germination and early seedling development ([Fig. 4b and c](#F4){ref-type="fig"}), as reported previously[@R25]. In contrast, the PP2C triple mutant *abi1hab1abi2* does not have a constitutive ABA response as strong as in *abi1-2hab1-1pp2ca-1* ([Fig. 4b and c](#F4){ref-type="fig"}), and does not show a strong constitutive activation of the SnRK2s ([Fig. 4a](#F4){ref-type="fig"}).

To our knowledge, this is the first report of *in vitro* reconstitution of a phytohormone signal transduction pathway using recombinant proteins. The *in vitro* reconstitution results are supported by the reconstitution assays in the protoplasts and by genetic analysis. The protoplast reconstitution assays enabled us to test the functions of nearly all members of the PYR/PYL family. Our results suggest that all in the family can function as ABA receptors in inducing gene expression. Although each of the proteins used in the reconstitution assays has been studied previously, it was not known how these components may connect to form a signaling pathway. Our study has revealed significant new insights into the mechanisms of action of these components. Our results suggest that the default state of the SnRK2 protein kinases is an autophosphorylated, active state, and that the SnRK2 kinases are kept inactive by the PP2Cs through physical interaction and dephosphorylation. We found that upon binding to ABA, the PYR/PYL receptor protein can disrupt or reduce the interaction between the SnRK2s and PP2Cs, and prevent the PP2Cs-mediated dephosphorylation of the SnRK2s, thus resulting in the activation of the SnRK2 kinases.

Successful reconstitution with the recombinant proteins implies that we have identified all essential core components of an ABA response pathway from hormone perception to phosphorylation of ABFs. Although ABA signaling in plants has been considered to be very complicated with numerous other proteins involved, our study reveals a surprising simplicity of the pathway and demonstrates that the PYR/PYLs, clade-A PP2Cs, SnRK2s, and ABFs are the only core components to complete the ABA regulation of gene expression. Since there are multiple family members for each of these core components, many combinations of them are possible. The functions of the family members may overlap, but their unique spatial and temporal expression patterns may confer some distinct functions in specific tissues. Extensive genetic analysis will be necessary to determine the *in planta* importance of specific combinations of the core components.

We suggest that the other proteins previously identified as involved in ABA responses, may function to modulate the expression and/or activities of one or more of the core components defined here. Calcium and reactive oxygen signaling, RNA metabolism and protein degradation are known to have important roles in regulating ABA sensitivity[@R2]-[@R4],[@R14],[@R26],[@R27]. It will be of great interest to determine how these processes may connect to one or more of the core components to impact ABA responses. It will also be interesting to determine whether other ABA response pathways such as ABA regulation of ion channels in guard cells[@R2],[@R3],[@R6] may also use components of the PYR/PYLs-PP2C-SnRK2 regulatory module and whether additional receptors and core signaling components are involved.

Methods Summary {#S1}
===============

Transient activity assays were performed in Arabidopsis mesophyll protoplasts from Columbia wild-type or SnRK2.2/2.3/2.621 as described previously (<http://genetics.mgh.harvard.edu/sheenweb>)[@R28]. Transfected protoplasts were incubated for 5 h in light in the presence of 0 (open bars) or 5 μM (+) ABA, and then used for measuring LUC and GUS activities as described previously[@R28]. Yeast two-hybrid and triple-hybrid assays, co-immunoprecipitation and BiFC assays were similar to those described previously[@R13]. Purification of GST-HAB1, His-PYR1 and His PYR1P88S was carried out as described previously[@R12]. GST, GST-ABI1, GST-ABF2 fragment, MBP and MBP-SnRK2.6 constructs were transformed into E. coli Rosetta cells (Novagen) and the recombinant proteins isolated by affinity purification. Purification of MBP-ABI1, MBP-ABI2, His-PYL8, His-PYL5 and His-SnRK2.6 was as described previously[@R13]. In-gel kinase assays were performed as described previously[@R20] with the modification that 300 μg protein was loaded for samples without ABA treatment. For germination assays, seeds were plated on MS medium containing 3% sucrose. In each experiment, at least 50 seeds per genotype were stratified at 4 °C for 3 d, and the presence of green cotyledons was scored after 6-day incubation at 23 °C.

Methods {#S2}
=======

Plant culture {#S3}
-------------

For protoplast isolation, *Arabidopsis thaliana* ecotype Columbia and snrk2.2/2.3/2.6 triple mutant plants were grown on Jiffy7 soil (Jiffy Products Ltd., Canada) in an environment-controlled chamber (illumination of 75 μmol m^−2^ s^−1^, photoperiod of 13 h light/11 dark, 22 °C).

Plasmid constructs for protoplast transient assay {#S4}
-------------------------------------------------

The RD29B promoter region[@R11] was PCR amplified form Columbia genomic DNA and cloned by replacing CBF3 promoter in CBF3-LUC protoplast expression vector. CBF3-LUC, UQ10-GUS, ABI1 and ABI1^G180D^ protoplast expression plasmid vectors were kindly provided by Jen Sheen (Massachusetts General Hospital, Boston, MA 02114). ABI1 was replaced with His-PYR1/His-PYLs/His-PYR^P88S^, HAB1-myc, ABF2-HA/ABF2 mutant versions, SnRK2-Flag/SnRK2.6^K50N^ sequences. All the plasmids were sequenced to confirm the sequence and avoid cloning errors. β-glucuronidase (GUS) reporter plasmid was used as internal control to normalize transfection efficiency in protoplast assays. Primers used for preparing protoplast expression vectors are as follows:

PRD29B-F: CG[GGATCC]{.ul}GTTGAATCTTGCGGAAGCA

PRD29B-R: CATG[CCATGG]{.ul}TTCAAGTGAATCAATCAAAC

HAB1-F: CATG[CCATGG]{.ul}AGGAGATGACTCCCGCAG

HAB1-R1: CAGATCCTCCTCAGAAATCAGCTTTTGCTC[AGGCCT]{.ul}GGTTCTGGTCTTGAACTTTC

HAB1-R2: GC[CTGCAG]{.ul}TCATAAGTCTTCTTCGCTTATTAATTTCTGTTCCAGATCCTCCTCAGAAA

ABF2-F: CG[GGATCC]{.ul}ATGGATGGTAGTATGAATTTGG

ABF2-R: GTCA[AGGCCT]{.ul}CCAAGGTCCCGACTCTGTCCT

SnRK2.2-F: CATG[CCATGG]{.ul}ATCCGGCGACTAATTCAC

SnRK2.2-Flag-R: GTCCTTGTAGTCAGA[AGGCCT]{.ul}GAGAGCATAAACTATCTC

SnRK2.2-Flag-Pst-R GC[CTGCAG]{.ul}TCACTTGTCATCGTCGTCCTTGTAGTCAGAAG

In SnRK2.2-Flag plasmid, SnRK2.2 was replaced with SnRK2.3 or SnRK2.6.

SnRK2.3-F: CATG[CCATGG]{.ul}ATCGAGCTCCGGTGACCA

SnRK2.3-R: GTCA[AGGCCT]{.ul}GAGAGCGTAAACTATCTCTCCGCT

SnRK2.6-F: CATG[CCATGG]{.ul}ATCGACCAGCAGTGAGT

SnRK2.6-R: GTCA[AGGCCT]{.ul}CATTGCGTACACAATCTCTC

His-PYR1 was constructed with following primers:

His- PYR1-F1: CACCATCACCCATGGATGCCTTCGGAGTTAACACCAG

His-PYR1-F2: CG[GGATCC]{.ul}ATGAAACATCACCATCACCATCACCCATGGATG

PYR1-R: GTCA[AGGCCT]{.ul}TCACGTCACCTGAGAACCACTTC

In His-PYR1 plasmid, PYR1 was replaced with PYLs with following primers:

PYL1-F: CATG[CCATGG]{.ul}ATGGCGAATTCAGAGTCCTCCTC

PYL1-R: GTCA[AGGCCT]{.ul}TTACCTAACCTGAGAAGAGTTG

PYL2-F: CATG[CCATGG]{.ul}ATGAGCTCATCCCCGGCCGTG

PYL2-R: GTCA[AGGCCT]{.ul}TTATTCATCATCATGCATAGGTG

PYL3-F: CATG[CCATGG]{.ul}ATGAATCTTGCTCCAATCCATG

PYL3-R: GTCA[AGGCCT]{.ul}TCAGGTCGGAGAAGCCGTGGA

PYL4-F: CATG[CCATGG]{.ul}ATGCTTGCCGTTCACCGTCCTTC

PYL4-R: GTCA[AGGCCT]{.ul}TCACAGAGACATCTTCTTCTTG

PYL5-F: CATG[CCATGG]{.ul}ATGAGGTCACCGGTGCAACTC

PYL5-R: GTCA[AGGCCT]{.ul}TTATTGCCGGTTGGTACTTCGAG

PYL6-F: CATG[CCATGG]{.ul}ATGCCAACGTCGATACAGTTTC

PYL6-R: GTCA[AGGCCT]{.ul}TTACGAGAATTTAGAAGTGTTCTC

PYL7-F: CATG[CCATGG]{.ul}ATGGAGATGATCGGAGGAGAC

PYL7-R: GTCA[AGGCCT]{.ul}TCAAAGGTTGGTTTCTGTATGA

PYL8-F: CATG[CCATGG]{.ul}ATGGAAGCTAACGGGATTGAGAAC

PYL8-R: GTCA[AGGCCT]{.ul}TTAGACTCTCGATTCTGTCGTG

PYL9-F: CATG[CCATGG]{.ul}ATGATGGACGGCGTTGAAGG

PYL9-R: GTCA[AGGCCT]{.ul}TCACTGAGTAATGTCCTGAGAAG

PYL10-F: CATG[CCATGG]{.ul}ATGAACGGTGACGAAACAAAGAAG

PYL10-R: GTCA[AGGCCT]{.ul}TCATATCTTCTTCTCCATAGATTCTG

PYL11-F: CATG[CCATGG]{.ul}ATGGAAACTTCTCAAAAATATC

PYL11-R: GTCA[AGGCCT]{.ul}TTACAACTTTAGATGAGCCACC

PYL12-F: CATG[CCATGG]{.ul}ATGAAAACATCTCAAGAACAGCA

PYL12-R: GTCA[AGGCCT]{.ul}TTAAGTGAGCTCCATCATCTTC

In vitro mutagenesis {#S5}
--------------------

ABF2-HA plasmid was used for in vitro mutagenesis by using The GeneTailor™ Site-Directed Mutagenesis System (Catalog no. 12397-014, Invitrogen) with the following mutagenic primers:

ABF2S26-R: ACCTTGTCTAGTCAACCCTCCACCTCCACCAC

ABF2S26A-F: AGGGTTGACTAGACAAGGTGCTATATACTCGTTG

ABF2S26D-F: AGGGTTGACTAGACAAGGTGATATATACTCGTTG

ABF2S86-R: GCCTTGCCTCTGCAGCTGCAAACCCTCTTG

ABF2S86A-F: CAGCTGCAGAGGCAAGGCGCTTTGACTCTGCCTC

ABF2S86D-F: CAGCTGCAGAGGCAAGGCGATTTGACTCTGCCTC

ABF2S94-R: AAGCGTTCGAGGCAGAGTCAACGAGCCTTG

ABF2S94A-R1: AAGCGTTCGAGGCAGAGTCAAAGCGCCTTG

VC-ABF2S94D-R1: AAGCGTTCGAGGCAGAGTCAAATCGCCTTG

ABF2S94A-F: ACTCTGCCTCGAACGCTTGCTCAGAAGACGGTTG

ABF2S94D-F: ACTCTGCCTCGAACGCTTGATCAGAAGACGGTTG

ABF2T135-R: TTGCTGCCTCTGACTCTGACTCTGACTCTG

ABF2T135A-F: TCAGAGTCAGAGGCAGCAAGCTTTAGGTGAAGTA

ABF2T135D-F: TCAGAGTCAGAGGCAGCAAGATTTAGGTGAAGTA

Protoplast isolation and transactivation assay {#S6}
----------------------------------------------

About four-week-old plants were used for protoplast isolation as described previously (<http://genetics.mgh.harvard.edu/sheenweb>)[@R28]. All the chemicals used in protoplast isolation were obtained from Sigma. About 0.5--1 mm width leaf strips cut from the middle part of leaves were vacuum infiltrated with enzyme solution containing 20 mM MES (pH 5.7), 1.5% (wt/vol) cellulase R10 (Yakult Pharmaceutical Ind. Co., Ltd., Japan), 0.4% (wt/vol) macerozyme R10 (Yakult Pharmaceutical Ind. Co., Ltd., Japan), 0.4 M mannitol and 20 mM KCl, 10 mM CaCl2, 1 mM β-mercaptoethanol (optional) and 0.1% BSA. After 30 minutes infiltration, leaf strips in enzyme solution was incubated in dark for 3h. Protoplasts were diluted with W5 (2 mM MES pH 5.7 containing 154 mM NaCl, 125 mM CaCl2 and 5 mM KCl) solution to a final concentration of 2 × 105 cells mL-1. After 30 min resting, W5 solution was removed and protoplasts were resuspended in MMg solution (4 mM MES pH 5.7 containing 0.4 M mannitol and 15 mM MgCl~2~). For transfection, 100 μL of protoplasts (2 × 104 cells) were mixed with plasmid constructs (in 10 μL) and 110 μl of PEG solution (40%, wt/vol, PEG4000 in ddH2O containing 0.2 M mannitol and 100 mM CaCl~2~). After 10 minute incubation, transfection was stopped by adding 440 μl of W5 solution. Protoplasts were harvested by centrifugation at 100 × g for 2 min at room temperature and resuspended in about 100 μl of W5 solution. Then, protoplasts were incubated WI solution (4 mM MES pH 5.7 containing 0.5 M mannitol and 20 mM KCl) with 0 or 5 μm (+) ABA for 5 h. Protoplasts were harvested by centrifugation at 100 × g for 2 min, frozen in liquid N~2~ and store at −80 °C until further use. The frozen protoplasts were resuspended in 100 μl of protoplast lysis buffer (2.5 mM Tris--phosphate pH 7.8 containing 1 mM DTT, 2 mM DACTAA, 10% (vol/vol) glycerol and 1% (vol/vol) Triton X-100). 100 μl LUC mix (Promega) was added in 10 μl of the lysate and LUC activity was measured with a plate reader (Wallac VICTOR2 plate reader). 2 μl of the protoplast lysate was mixed with 10 μl of MUG substrate mix (10 mM Tris--HCl pH 8 containing 1 mM MUG and 2 mM MgCl~2~) and incubated for 30 min at 37 °C. The reaction was stopped by adding 10 μl of 0.2 M Na~2~CO~3~ and the fluorescence of MU was quantified using a plate reader (Wallac VICTOR2 plate readers).

The RD29B promoter fused with LUC coding sequence was used as an ABA-responsive reporter gene (7 μg plasmid per transfection). ZmUBQ::GUS was included in each sample as an internal control (3 μg per transfection). ABF2-HA and its mutant versions, SnRK2.6-Flag and SnRK2.6K50N-Flag, His-PYR/PYLs and HAB1-myc plasmid constructs were used at 3 μg per transfection, while ABI1 was used at 2 μg per transfection.

*In vitro* phosphatase and kinase assays {#S7}
----------------------------------------

MBP-SnRK2.6 (1 μg), MBP (1 μg) or FLAG-SnRK2.6 on beads was incubated with GST-ABI1 (1 μg), GST (1 μg), His-PYR1 (1 μg) and/or His-PYR1^P88S^ (1 μg) as indicated in 40 μl phosphatase buffer (50 mM Tris-HCl, pH 7.0, 60 mM magnesium acetate, 0.1 mM EGTA and 0.1% β-mercapto ethanol) containing indicated concentration of (+)-ABA (Biosynth AG, Switzerland) at 30 °C for 20 min. After removal of the solution, GST-ABF2 fragment (10 μg) was added. The reaction mixture (20 μl) contained 25 mM Tris (pH 7.4), 12 mM MgCl~2~, 1 μM ATP, 5 μCi \[γ-^32^P\] ATP, 1 mM DTT, 1mM Na~3~VO~4~, 5 mM NaF. The reaction mixtures were incubated at 30 °C for 30 min. The reaction was stopped by the addition of Laemmli\'s sample buffer, and the mixtures were then subjected to SDS-polyacrylamide gel electrophoresis. Radioactivity was detected with a Typhoon phosphoimager (GE Healthcare). SnRK2.6 kinase deactivation assays were done by previous incubation with protein phosphatase for 30 minutes at room temperature. Assays to test recovery of SnRK2.6 activity were done by incubation for 10 min of the protein phosphatase together with the receptors in the presence of 1 μM (+) ABA.

To measure phosphate release from synthetic phosphopeptide, the phospho peptide (10 nmol) from Biomatik corporation (DE) was incubated with 1 μg of ABI1 or GST in the phosphatase buffer (40 μl) at 30 °C for 10 min. Released phosphate was measured as described previously[@R29].

Construction of plasmids for yeast two-hybrid and triple-hybrid analysis {#S8}
------------------------------------------------------------------------

The coding sequence of SnRK2.6, SnRK2.2, SnRK2.3 was amplified by PCR using the following pairs of primers: F4g33950 and R4g33950, F3g50500 and R3g50500, F5g66880 and R5g66880, respectively. The PCR product was initially cloned into pCR8/GW/TOPO, doubly digested EcoRI-SalI and cloned into pGBT9, where the kinase coding sequences were fused to the GAL4 DNA-binding domain (GBD). pGBT9 constructs where SnRK2s acted as baits were faced in two-hybrid assays with the following pGADT7 constructs: ABI1, ABI2 and HAB1, where the PP2C coding sequences were fused to the GAL4 activation domain (GAD).

To perform triple-hybrid experiments, the SnRK2.6 EcoRI-SalI fragment described above was cloned into the pBridge vector (Clontech), where the kinase coding sequence is fused to GBD. Next, the coding sequences of PYL8 and PYL5 were cloned into the NotI site of pBridge-OST1. To reproduce the yeast two-hybrid interaction described above, yeast host AH109 was co-transformed with one of the following plasmids, pGADT7-ABI1/pGADT7-ABI2/pGADT7-HAB1, encoding GAD-PP2C fusions and pBridge-OST1, encoding a GBD-OST1 fusion; whereas to test the interference of ABA-receptors on this interaction, pBridge-OST1+PYL8 and pBridge-OST1+PYL5 were employed

BiFC {#S9}
----

Experiments were performed as described previously[@R13]. Constructs were made in the pSPYNE-35S[@R30] as well as the Gateway vector pYFP^C^43 (kindly provided by A. Ferrando). ABI1 coding sequence was excised from pCR8/GW/TOPO as a BamHI-SmaI fragment and cloned into pSPYNE-35S. The coding sequences of SnRK2.6, SnRK2.2, SnRK2.3 and ΔCOST1, previously cloned into pCR8/GW/TOPO, were recombined by LR reaction into pYFP^C^43 destination vector.

Immunoprecipitation {#S10}
-------------------

Protein extracts for immunodetection experiments were prepared from *N. benthamiana* leaves infiltrated with *Agrobacterium tumefaciens* C58C1 (pGV2260) transformed with the different fusion proteins containing the SnRK2.6/OST1, the C-terminal deletion of SnRK2.6, the N-terminal deletion and full-length ABI1. Protein extracts from the transfected plants were used for immunoprecipitation at 4 °C with super-paramagnetic MACS microbeads coupled to monoclonal anti c-myc antibody (<http://www.miltenyibiotec.com>). The antigen-antibody complex was eluted, fractionated on an 8% SDS-PAGE gel and transferred onto Immobilon-P membranes (Millipore), and probed either with monoclonal anti-c-myc (clone 9E10, Roche) or anti-GFPC (clone JL-8, Clontech) as primary antibodies and ECL anti-mouse-peroxidase (GE Healthcare) as secondary antibody. Detection was performed using the ECL advance western blotting detection kit (GE Healthcare).

To immunoprecipitate SnRK2.6, three weeks old seedlings of transgenic plants expressing FLAG-SnRK2.6 treated with 100 μM ABA was used. Protein extracts were incubated with anti-FLAG antibody beads (Sigma) for 2 h at 4 °C. The beads were washed six times with the prechilled extraction buffer.
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![Reconstitution of ABA signaling pathway for stress responsive gene expression in *Arabidopsis* protoplasts\
**a**, SnRK2-mediated phosphorylation of ABF2 is sufficient for ABA-responsive gene expression. **b**, Reconstitution of ABA signaling pathway by co-expression of PYR1, ABI1, SnRK2.6 and ABF2. **c**, econstitution of ABA signaling pathway with different members of the PYR/PYL family. **d**, Reconstitution using different combinations of the core components. Protoplasts (2 × 10^4^) from the *snrk2.2/3/6* triple mutant were used except in (d), where protoplasts from the Col-0 wild-type plants were used. The *RD29B::LUC* and *ZmUBQ*::*GUS* were used as the ABA responsive reporter and internal control, respectively. After transfection, protoplasts were incubated for 5 h under light and in the presence of 0 (open bars) or 5 μM (solid bars) ABA. Error bars, mean ± s.e.m. (n=3).](nihms-155225-f0001){#F1}

![ABI1 and ABI2 inhibit SnRK2.6 by dephosphorylation\
**a**, SnRK2.6 is deactivated by ABI1. MBP or MBP-SnRK2.6 treated without (−) or with GST-ABI1 or GST was incubated with GST-ABF2 fragment (amino acids Gly73 to Gln119) in the presence of \[γ^32^P\]-ATP. In the furthest right lane (post), GST-ABI1 was added after phosphorylation of GST-ABF2 fragment by MBP-SnRK2.6. Bands of GST-ABF2 fragment and MBP-SnRK2.6 are indicated by an arrow and an arrowhead, respectively. Radioactivities of GST-ABF2 fragment bands were measured with a phospho-imager and were normalized, taking the radioactivity of the band by MBP-SnRK2.6 without ABI1 treatment as 1 (mean ± s.e.m., n = 5). **b**, Coomassie staining of purified MBP, SnRK2.6, ABF2, GST and GST-ABI1. **c**, FLAG-SnRK2.6 extracted from transgenic plants before and after ABA treatment was used instead of MBP-SnRK2.6 in (a). Coomassie staining, autoradiography and relative radioactivities (mean ± s.e.m. n = 5) of GST-ABF2 fragment are shown. Western blotting with anti-FLAG antibody shows FLAG-SnRK2.6 protein amount. **d**, Autoradiography of autophosphorylated SnRK2.6 showing dephosphorylation of SnRK2.6 by MBP-ABI1 and MBP-ABI2 and the effect of PYL8 and PYL5, respectively, in the presence of 1 μM ABA. **e**, Phosphate release from synthetic peptide HSQPKpSTVGTP, corresponding to amino acids 170-180 of SnRK2.6.](nihms-155225-f0002){#F2}

![The combined effect of ABA, PYR1 and ABI1 on SnRK2.6 phosphorylation of GST-ABF2 fragment *in vitro*\
**a**, Reconstitution of ABA regulation of ABF2 phosphorylation. MBP-SnRK2.6 treated with GST-ABI1 and His-tagged wild type PYR1 (w) or mutated PYR1P88S (m) in the absence (−) or presence (+) of 2 μM (+)-ABA was incubated with GST-ABF2 fragment (amino acids Gly73 to Gln119) in the presence of \[γ^32^P\]-ATP. Coomassie staining, autoradiography and relative radioactivities of GST-ABF2 fragment are shown. Radioactivities of GST-ABF2 fragment were normalized, taking the radioactivity of the band with PYR1P88S in the absence of ABA as 1 (mean ± s.e.m., n = 5). **b**, Coomassie staining of PYR1 (w) and PYR1P88S (m). **c**, ABA dose response. MBP-SnRK2.6, GST-ABI1 and His-PYR1 were incubated with different concentrations of (+)-ABA before the kinase assay using GST-ABF2 fragment as substrate. Coomassie staining, autoradiography and relative radioactivities (taking the radioactivity of the band in the absence of ABA as 1; mean ± s.e.m., n = 9 for \< 5 μM, n = 4 for 5 μM or more) of GST-ABF2 fragment are shown.](nihms-155225-f0003){#F3}

![Effect of PP2C mutations on ABA response phenotypes and kinase activities of SnRK2s\
**a**, In-gel kinase assay showing the activities of SnRK2s in the *abi1/hab1/abi2* (*i2*) and *abi1/hab1/pp2ca* (*ca*) triple mutants. The *snrk2.2/2.3/2.6* was used as a control. GST-fused ABF2 fragment (amino acids Gly73 to Gln119) was used as the phosphorylation substrate. The expected positions of SnRK2.6 and SnRK2.2/2.3 are indicated by arrow and arrowhead, respectively. Radioactivities of the upper and lower bands were normalized, taking the radioactivity of the upper band in WT as 1 (mean ± s.e.m., n = 3). **b**, The PP2C triple mutants show ABA hypersensitivity during germination and early seedling development. Photograph of plants of the indicated genotypes growing on MS medium with 3% sucrose for 14 d. **c**, The percentage of seedlings with green cotyledons 6 d after the end of stratification is shown (mean ± s.e.m., n = 3).](nihms-155225-f0004){#F4}
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